Stanley-Laman Group’s Amgen AMGN Stock Holding History

Stanley-Laman Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.39M	Buy	12,465 +269	+2%	+$95.9K	0.54%	67
2025 Q4	$3.99M	Buy	12,196 +455	+4%	+$144K	0.51%	74
2025 Q3	$3.31M	Sell	11,741 -493	-4%	-$143K	0.47%	88
2025 Q2	$3.42M	Sell	12,234 -981	-7%	-$278K	0.51%	90
2025 Q1	$4.12M	Buy	13,215 +3,262	+33%	+$963K	0.63%	58
2024 Q4	$2.59M	Sell	9,953 -1,020	-9%	-$303K	0.36%	117
2024 Q3	$3.54M	Buy	10,973 +237	+2%	+$77.5K	0.5%	94
2024 Q2	$3.35M	Buy	+10,736	New	+$3.15M	0.48%	99
2023 Q4	–	Sell	-935	Closed	-$251K	–	235
2023 Q3	$251K	Hold	935	–	–	0.04%	207
2023 Q2	$208K	Buy	935 +28	+3%	+$6.5K	0.03%	228
2023 Q1	$219K	Buy	+907	New	+$223K	0.04%	214
2021 Q2	–	Sell	-6,793	Closed	-$1.69M	–	247
2021 Q1	$1.69M	Buy	6,793 +178	+3%	+$42.5K	0.28%	117
2020 Q4	$1.52M	Buy	6,615 +345	+6%	+$79.5K	0.27%	107
2020 Q3	$1.59M	Buy	6,270 +289	+5%	+$71.6K	0.35%	76
2020 Q2	$1.41M	Buy	5,981 +531	+10%	+$121K	0.34%	76
2020 Q1	$1.1M	Buy	5,450 +1,113	+26%	+$243K	0.34%	81
2019 Q4	$1.04M	Sell	4,337 -73	-2%	-$16.1K	0.25%	133
2019 Q3	$853K	Sell	4,410 -627	-12%	-$120K	0.21%	151
2019 Q2	$928K	Buy	5,037 +84	+2%	+$15K	0.22%	150
2019 Q1	$941K	Buy	4,953 +232	+5%	+$44.3K	0.23%	141
2018 Q4	$919K	Buy	4,721 +162	+4%	+$31.6K	0.26%	120
2018 Q3	$945K	Buy	4,559 +32	+0.7%	+$6.31K	0.23%	133
2018 Q2	$836K	Buy	4,527 +542	+14%	+$95.9K	0.19%	160
2018 Q1	$679K	Buy	3,985 +306	+8%	+$56.2K	0.15%	188
2017 Q4	$640K	Sell	3,679 -219	-6%	-$38.8K	0.14%	204
2017 Q3	$727K	Buy	3,898 +325	+9%	+$57.6K	0.19%	122
2017 Q2	$615K	Sell	3,573 -20	-0.6%	-$3.25K	0.17%	130
2017 Q1	$590K	Sell	3,593 -1,813	-34%	-$301K	0.16%	146
2016 Q4	$790K	Buy	5,406 +1,133	+27%	+$171K	0.24%	131
2016 Q3	$713K	Buy	4,273 +272	+7%	+$46K	0.29%	123
2016 Q2	$609K	Sell	4,001 -1,428	-26%	-$222K	0.24%	147
2016 Q1	$814K	Sell	5,429 -7,191	-57%	-$1.07M	0.15%	135
2015 Q4	$2.05M	Buy	12,620 +3,265	+35%	+$513K	0.35%	92
2015 Q3	$1.29M	Buy	9,355 +3,477	+59%	+$548K	0.26%	96
2015 Q2	$902K	Sell	5,878 -473	-7%	-$75.8K	0.17%	152
2015 Q1	$1.01M	Buy	6,351 +1,097	+21%	+$173K	0.19%	134
2014 Q4	$837K	Buy	5,254 +624	+13%	+$97.2K	0.16%	145
2014 Q3	$650K	Buy	4,630 +2,391	+107%	+$312K	0.13%	165
2014 Q2	$265K	Buy	2,239 +68	+3%	+$7.87K	0.05%	255
2014 Q1	$268K	Buy	+2,171	New	+$263K	0.05%	279

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stanley-Laman Group's AMGN Position: Q1 2026 in Review

Stanley-Laman Group increased its Amgen (AMGN) stake by 2.2% in Q1 2026, buying an estimated $95.9K and bringing the position to 12,465 shares worth $4.39M. The position accounts for 0.54% of the portfolio, ranked #67.

Stanley-Laman Group first reported a position in AMGN in Q1 2014 and has held it in 40 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Stanley-Laman Group held 12,465 shares of Amgen worth $4.39M as of Q1 2026.
Stanley-Laman Group bought 269 Amgen shares in Q1 2026, an estimated $95.9K.
Amgen made up 0.54% of Stanley-Laman Group's portfolio in Q1 2026, its #67 holding.
Stanley-Laman Group first reported a position in Amgen in Q1 2014 and has held it in 40 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Stanley-Laman Group's 13F filing for Q1 2026, filed 16 Apr 2026.